Treatment Registry
TR-0637 ActiveRecorded September 2, 2026

Unspecified GLP-1

Sold by Remi Meds · every unspecified glp-1 record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$249

Medication · Personalized GLP-1, 0.25-0.5 mg/week (starting dose)$249

Added from the figures recorded below.

Price

TermPer monthCharged today
Personalized GLP-1, 0.25-0.5 mg/week (starting dose)

GLP-1 dose 0.25 mg per week | $249/mo ~ starting dose

source

Per month$249Charged today$249
Personalized GLP-1, 1-2.4 mg/week

GLP-1 dose 1 mg per week | $349/mo

source

Per month$349Charged today$349
Visit Remi Meds

We earn nothing from this link. Remi Meds has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyStrive Pharmacy, Gilbert AZ
PrescriberBoth
Cancellation“You can always login to your https://remimeds.com account before your products ship to change your address, method of payment or to cancel your subscription.”

Not yet checked: states, membership and consult fee.

Recorded from remimeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Site never names semaglutide or tirzepatide specifically — the two products are called 'Personalized GLP-1' and 'Personalized GLP-1/GIP +B12', described only as a 'custom-formulated version of the medication used for blood sugar control'; recorded as unspecified GLP-1 rather than inferring compounded semaglutide/tirzepatide. FAQ says orders 'cannot be changed or cancelled once submitted' while the Returns and Refunds page says you can cancel your subscription before it ships — the two pages contradict each other on cancellation.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0637
Readings
1

Related records

Unspecified GLP-1 at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 72 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Remi Meds unspecified GLP-1 (TR-0637). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0637

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.